Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used

di Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicazione 2010

A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs

di Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicazione 2011

A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients

di Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicazione 2013

Reply to Moonan and Weis, Seaworth et al, and Nunn and Phillips

di Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicazione 2013

Measuring health-related quality of life in tuberculosis: a systemic review - Response

di Weis, Stephen E, Pasipanodya, Jotam G
Pubblicazione 2010

Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy

di Pasipanodya, Jotam G., Srivastava, Shashikant, Gumbo, Tawanda
Pubblicazione 2012

Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease

di Deshpande, Devyani, Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicato in Antimicrob Agents Chemother (2016)

pH Conditions under Which Pyrazinamide Works in Humans

di Srivastava, Shashikant, Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicato in Antimicrob Agents Chemother (2017)

Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse

di Magombedze, Gesham, Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicato in Commun Biol (2021)

Therapy duration and long-term outcomes in extra-pulmonary tuberculosis

di Pusch, Tobias, Pasipanodya, Jotam G, Hall, Ronald G, Gumbo, Tawanda
Pubblicazione 2014

In Silico Children and the Glass Mouse Model: Clinical Trial Simulations To Identify and Individualize Optimal Isoniazid Doses in Children with Tuberculosis

di Jeena, Prakash M., Bishai, William R., Pasipanodya, Jotam G., Gumbo, Tawanda
Pubblicazione 2011

Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability

di Srivastava, Shashikant, Pasipanodya, Jotam G., Meek, Claudia, Leff, Richard, Gumbo, Tawanda
Pubblicazione 2011

Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy

di Gumbo, Tawanda, Pasipanodya, Jotam G., Wash, Peter, Burger, André, McIlleron, Helen
Pubblicazione 2014

Reply to “Breakpoints and Drug Exposure Are Inevitably Closely Linked”

di Gumbo, Tawanda, Pasipanodya, Jotam G., Wash, Peter, Burger, André, McIlleron, Helen
Pubblicato in Antimicrob Agents Chemother (2015)

Pegylated Interferon Fractal Pharmacokinetics: Individualized Dosing for Hepatitis C Virus Infection

di Jain, Mamta K., Pasipanodya, Jotam G., Alder, Lara, Lee, William M., Gumbo, Tawanda
Pubblicazione 2013

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo

di Deshpande, Devyani, Srivastava, Shashikant, Nuermberger, Eric, Pasipanodya, Jotam G., Swaminathan, Soumya, Gumbo, Tawanda
Pubblicato in Clin Infect Dis (2016)

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way

di Deshpande, Devyani, Srivastava, Shashikant, Nuermberger, Eric, Pasipanodya, Jotam G., Swaminathan, Soumya, Gumbo, Tawanda
Pubblicato in Clin Infect Dis (2016)

Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

di Pasipanodya, Jotam G., McIlleron, Helen, Burger, André, Wash, Peter A., Smith, Peter, Gumbo, Tawanda
Pubblicazione 2013

Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients

di Modongo, Chawangwa, Pasipanodya, Jotam G., Zetola, Nicola M., Williams, Scott M., Sirugo, Giorgio, Gumbo, Tawanda
Pubblicato in Antimicrob Agents Chemother (2015)

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

di Srivastava, Shashikant, Modongo, Chawanga, Siyambalapitiyage Dona, Chandima W., Pasipanodya, Jotam G., Deshpande, Devyani, Gumbo, Tawanda
Pubblicato in Antimicrob Agents Chemother (2016)